✦ LIBER ✦

Clinical Efficacy and Prospects for Use of Pegylated Liposomal Doxorubicin in the Treatment of Ovarian and Breast Cancers

✍ Scribed by Dr Franco M. Muggia

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of bevacizumab and pegylated lip

✍ Kazuya Kudoh; Masashi Takano; Hiroko Kouta; Ryoko Kikuchi; Tsunekazu Kita; Morik 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 402 KB

Phase II Study of Bortezomib and Pegylat

✍ William J. Irvin Jr.; Robert Z. Orlowski; Wing-Keung Chiu; Lisa A. Carey; France 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 766 KB

Evaluation of Pegylated Liposomal Doxoru

✍ Hao Lin; Chih-Wen Tseng; Hung-Yaw Chang; Hsien-Ming Lu; Yu-Che Ou; Chan-Chao Cha 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Pegylated liposomal doxorubicin and rena

✍ Shavit, Linda; Lifschitz, Meyer D; Gabizon, Alberto; Kwa, Maryann; Muggia, Franc 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 69 KB

Safety and efficacy of metronomic non-pe

✍ L. Manso, N. Valdiviezo, J. Sepúlveda, E. Ciruelos… 📂 Article 📅 2012 🏛 Springer Milan 🌐 Spanish ⚖ 158 KB

Pegylated liposomal doxorubicin with bev

✍ S. Czok; A. Jewell; S. Shawki; L. Boyd; H. Smith; S. Blank; C. Muller; C. Versch 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 51 KB